Literature DB >> 19003912

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Svetlana Marukian1, Christopher T Jones, Linda Andrus, Matthew J Evans, Kimberly D Ritola, Edgar D Charles, Charles M Rice, Lynn B Dustin.   

Abstract

UNLABELLED: Hepatitis C virus (HCV) replicates primarily in the liver, but HCV RNA has been observed in association with other tissues and cells including B and T lymphocytes, monocytes, and dendritic cells. We have taken advantage of a recently described, robust system that fully recapitulates HCV entry, replication and virus production in vitro to re-examine the issue of HCV infection of blood cell subsets. The HCV replicase inhibitor 2'C-methyl adenosine was used to distinguish HCV RNA replication from RNA persistence. Whereas cell culture-grown HCV replicated in Huh-7.5 hepatoma cells, no HCV replication was detected in B or T lymphocytes, monocytes, macrophages, or dendritic cells from healthy donors. No blood cell subset tested expressed significant levels of Claudin-1, a tight junction protein needed for HCV infection of Huh-7.5 cells. A B cell line expressing high levels of Claudin-1, CD81, and scavenger receptor BI remained resistant to HCV pseudoparticle infection. We bypassed the block in HCV entry by transfecting HCV RNA into blood cell subsets. Transfected RNA was not detectably translated and induced high levels of interferon-alpha. Supernatants from HCV RNA-transfected macrophages inhibited HCV replication in Huh-7.5 cells.
CONCLUSION: We conclude that multiple blocks prevent blood cells from supporting HCV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003912      PMCID: PMC2592497          DOI: 10.1002/hep.22550

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.

Authors:  J Boisvert; X S He; R Cheung; E B Keeffe; T Wright; H B Greenberg
Journal:  J Infect Dis       Date:  2001-08-30       Impact factor: 5.226

2.  Dendritic cell susceptibility to hepatitis C virus genotype 1 infection.

Authors:  Maria-Cristina Navas; Anne Fuchs; Evelyne Schvoerer; Alain Bohbot; Anne-Marie Aubertin; Françoise Stoll-Keller
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

3.  Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.

Authors:  A Fornasieri; P Bernasconi; M L Ribero; R A Sinico; M Fasola; J Zhou; G Portera; A Tagger; A Gibelli; G D'amico
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

5.  Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.

Authors:  Flavien Bernardin; Leslie Tobler; Irina Walsh; Joan Dunn Williams; Mike Busch; Eric Delwart
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

6.  Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells.

Authors:  Julien Laporte; Christine Bain; Patrick Maurel; Genevieve Inchauspe; Henri Agut; Annie Cahour
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

7.  Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Authors:  Vicky M-H Sung; Shigetaka Shimodaira; Alison L Doughty; Gaston R Picchio; Huong Can; T S Benedict Yen; Karen L Lindsay; Alexandra M Levine; Michael M C Lai
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection.

Authors:  Nadège Goutagny; Ahmed Fatmi; Victor De Ledinghen; François Penin; Patrice Couzigou; Geneviève Inchauspé; Christine Bain
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

9.  Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.

Authors:  Anne Fournillier; Delphine Freida; Thierry Defrance; Philippe Merle; Christian Trépo; Geneviève Inchauspé
Journal:  J Med Virol       Date:  2004-04       Impact factor: 2.327

10.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  129 in total

1.  Investigation of residual hepatitis C virus in presumed recovered subjects.

Authors:  Kei Fujiwara; Robert D Allison; Richard Y Wang; Patricia Bare; Kentaro Matsuura; Cathy Schechterly; Krishna Murthy; Francesco M Marincola; Harvey J Alter
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425

2.  Modeling hepatitis C virus infection using human induced pluripotent stem cells.

Authors:  Robert E Schwartz; Kartik Trehan; Linda Andrus; Timothy P Sheahan; Alexander Ploss; Stephen A Duncan; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.

Authors:  Andreas Walker; Kathrin Skibbe; Eike Steinmann; Stephanie Pfaender; Thomas Kuntzen; Dominik A Megger; Svenja Groten; Barbara Sitek; Georg M Lauer; Arthur Y Kim; Thomas Pietschmann; Todd M Allen; Joerg Timm
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

4.  Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds.

Authors:  Chen-Jei Tai; Chia-Lin Li; Cheng-Jeng Tai; Chien-Kai Wang; Liang-Tzung Lin
Journal:  J Vis Exp       Date:  2015-10-29       Impact factor: 1.355

5.  Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Authors:  Elisavet Serti; Jens M Werner; Michael Chattergoon; Andrea L Cox; Volker Lohmann; Barbara Rehermann
Journal:  Gastroenterology       Date:  2014-03-28       Impact factor: 22.682

6.  Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.

Authors:  Kathleen McCaffrey; Irene Boo; Kevin Tewierek; Mark L Edmunds; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 8.  Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.

Authors:  Lynn B Dustin; Edgar D Charles
Journal:  Antivir Ther       Date:  2012-12-07

9.  Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.

Authors:  Timothy Sheahan; Naoko Imanaka; Svetlana Marukian; Marcus Dorner; Peng Liu; Alexander Ploss; Charles M Rice
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

10.  Hepatitis C virus RNA functionally sequesters miR-122.

Authors:  Joseph M Luna; Troels K H Scheel; Tal Danino; Katharina S Shaw; Aldo Mele; John J Fak; Eiko Nishiuchi; Constantin N Takacs; Maria Teresa Catanese; Ype P de Jong; Ira M Jacobson; Charles M Rice; Robert B Darnell
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.